Where is IntiQuan located?

IntiQuan is headquartered in Basel, Switzerland.

How many employees does IntiQuan have?

As of May 31, 2026, the latest employee count at IntiQuan is 20.

Is IntiQuan a funded company?

IntiQuan is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does IntiQuan rank among its competitors?

IntiQuan ranks 10th amongst 79 active competitors, of which 4 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was InSilicoTrials, which secured $3.5M in Jul, 2020.

Who are the top competitors of IntiQuan?

IntiQuan's top competitors include InSilicoTrials, CONTINUUM India and Veeda Clinical Research. Among them, InSilicoTrials secured the most recent funding round in July, 2020.

IntiQuan - 2026 Company Profile & Competitors

IntiQuan's employee count trend

IntiQuan has 20 employees as of May 26. Here is IntiQuan's employee count trend over the years:

Uncover IntiQuan's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of IntiQuan include InSilicoTrials, CONTINUUM India and Veeda Clinical Research. Here is the list of Top 10 competitors of IntiQuan, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	InSilicoTrials 2016, Milan (Italy), Series A	Provider of healthcare simulation services	$3.5M	United Ventures, Pi Campus & 3 others	45/100
2nd	CONTINUUM India 2018, Chandigarh (India), Unfunded	CRO focused on providing pharmacometric services	-	-	38/100
3rd	Veeda Clinical Research 2004, Ahmedabad (India), Unfunded	Provider of contract research organization services, supporting the development of biotherapeutics and small molecules	-	CX Partners	36/100
4th	Trypsin Chymotrypsin 2021, Panchkula (India), Unfunded	CRO focused on clinical trials management, pharmacovigilance, and biopharmaceuticals development	-	-	33/100
5th	Generable 2016, New York City (United States), Seed	Bayesian computational oncology, providing Stan-based modeling, optimization, and a HIPAA-compliant cloud	$120K	Techstars	31/100
6th	Resero Analytics 2018, Indianapolis (United States), Seed	Developer of software for analysis, interpretation, and reporting of study results	-	Charles River Laboratories	30/100
7th	Pharmetheus 2012, Uppsala (Sweden), Unfunded	Pharmacometric services for drug development	-	-	30/100
8th	Model Answers 2005, Brisbane (Australia), Acquired	PK/PD modelling, simulation and analysis services	-	-	28/100
9th	Pharmakinetic 2020, Nottingham (United Kingdom), Unfunded	Provider of pharmacokinetics, DMPK, clinical pharmacology, scientific review, and training	-	-	27/100
10th	IntiQuan 2015, Basel (Switzerland), Acquired	Provider of PK/PD modeling services	-	-	27/100